ENDRA Life Sciences, Inc. NDRAW 深 滬
已收盤 05-12 16:00:00 美东时间
0.03
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.03
- 總市值 124.92万
- 52周最高 0.72
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.01
- 委 比 0.00%
- 總股本 4164.02万
- 歷史最高 2.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.01
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ENDRA Life Sciences Q1 EPS $(1.09) Beats $(1.14) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.14) by 4.39 percent. This is a 41.4 percent increase over losses of $(1.86) per share from
05-18 20:04
ENDRA Life Sciences Reports Multi-Site Validation And MRI-Level Accuracy Of TAEUS Liver Device
The analysis combined data from 64 patients in the U.S. and Canada, including an external validation site in London, Ontario, across independent operators and patient populations. TAEUS Liver's thermoacoustic fat
05-14 20:09
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk
ENDRA Life Sciences ( ($NDRA) ) just unveiled an update. ENDRA Life Sciences di...
04-21 20:37
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
04-08 01:30
ENDRA Life Sciences Q4 EPS $(3.25) Misses $(1.95) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(3.25) per share which missed the analyst consensus estimate of $(1.95) by 66.67 percent. This is a 55.78 percent increase over losses of $(7.35) per share
04-01 05:22
快讯 | ENDRA Life Sciences 第四季度运营费用为 USD 160万
ENDRA Life Sciences Q4 Operating Expenses USD 1.6 Million
04-01 04:05
ENDRA Life Sciences Says On March 19 , Reduced Number Of Employees In Order To Reduce Cash Expenditures And Extend Its Operational Runway; Expects To Incur Pre-Tax Cash Charges Of ~$51,000 Associated With Severance Payments To Former Employees
Costs Associated with Exit or Disposal Activities. On March 25, 2026, ENDRA Life Sciences Inc. (the "Company") announced that it has initiated a process to evaluate a range of strategic alternatives aimed at
03-25 21:28
BRIEF-Endra Life Sciences Initiates Review Of Strategic Alternatives To Maximize Shareholder Value
BRIEF-Endra Life Sciences Initiates Review Of Strategic Alternatives To Maximize Shareholder Value ENDRA Life Sciences Inc NDRA.O : ENDRA LIFE SCIENCES INITIATES REVIEW OF STRATEGIC ALTERNATIVES TO MAXIMIZE SHAREHOLDER VALUE ENDRA LIFE SCIENCES INC - BOARD TO EVALUATE STRATEGIC INVESTMENTS, MERGERS,
03-25 21:18
Why AMTD Digital Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
AMTD Digital Inc - ADR (NYSE: HKD) jumped 24.4% in pre-market trading after reporting a 565.7% increase in FY25 revenue results to $136.1 million.
03-02 17:26
